You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Age-related macular degeneration

Showing 26 - 50 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Neovascular (Wet) Age-related Macular Degeneration (nAMD) Trial (EXG102-031)

Not yet recruiting
  • Neovascular (Wet) Age-related Macular Degeneration (nAMD)
  • EXG102-031
  • (no location specified)
Jun 13, 2023

OKKO Health Hyperacuity, Contrast and Colour Game Validation in

Recruiting
  • Age-Related Macular Degeneration
    • Bristol, United Kingdom
      Bristol
    Nov 16, 2022

    Age Related Macular Degeneration (AMD) Trial in Decatur (SPIN, Non-aerobic, stretching/balance intervention Control)

    Not yet recruiting
    • Age Related Macular Degeneration (AMD)
    • SPIN
    • Non-aerobic, stretching/balance intervention Control
    • Decatur, Georgia
      Atlanta VA Medical and Rehab Center, Decatur, GA
    Jun 26, 2023

    Early Real-world Evidence of Brolucizumab in Neovascular

    Completed
    • Neurovascular Age-related Macular Degeneration
      • Bangalore, India
      • +3 more
      Apr 26, 2023

      Neovascular Age-related Macular Degeneration Trial in Beijing (IBI333)

      Not yet recruiting
      • Neovascular Age-related Macular Degeneration
      • IBI333
      • Beijing, Beijing, China
        Peking Union Medical College Hospital, Chinese Academy of Medica
      Nov 28, 2022

      Age-Related Macular Degeneration, Retinitis Pigmentosa, Ultrasound Therapy; Complications Trial (Non-invasive ultrasound retinal

      Not yet recruiting
      • Age-Related Macular Degeneration
      • +2 more
      • Non-invasive ultrasound retinal stimulation Device
      • (no location specified)
      Jun 19, 2023

      Non-invasive Optical Angiography in Age-related Macular

      Recruiting
      • Age Related Macular Degeneration
      • Non-invasive OCT based optical angiography
      • +3 more
      • Vienna, Austria
        Medical University of Vienna
      Jan 13, 2023

      Age-Related Macular Degeneration, Geographic Atrophy Trial in Holon (smaller incision, new generation implantable miniature

      Not yet recruiting
      • Age-Related Macular Degeneration
      • Geographic Atrophy
      • smaller incision, new generation implantable miniature telescope (SING-IMT)
      • Holon, Tel Aviv, Israel
        Wolfson Medical Center
      Jul 3, 2023

      Data of Intravitreal Aflibercept Injection in Patients of Wet

      Completed
      • Wet Age-related Macular Degeneration
      • Aflibercept (Eylea, BAY86-5321)
      • Multiple Locations, India
        Many Locations
      Feb 2, 2023

      Age-Related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial (Active microcurrent therapy)

      Completed
      • Age-Related Macular Degeneration
      • Nonexudative Age-related Macular Degeneration
      • Active microcurrent therapy
      • (no location specified)
      Jan 28, 2023

      Age-Related Macular Degeneration Trial run by the NEI (iPSC-derived RPE/PGLA transplantation)

      Recruiting
      • Age-Related Macular Degeneration
      • iPSC-derived RPE/PLGA transplantation
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      Geographic Atrophy Trial (BI 771716)

      Not yet recruiting
      • Geographic Atrophy
      • BI 771716
      • (no location specified)
      Aug 29, 2023

      Age-Related Macular Degeneration, Dry Age-related Macular Degeneration, Nonexudative Age-related Macular Degeneration Trial in

      Recruiting
      • Age-Related Macular Degeneration
      • +2 more
      • i-Lumen(TM) AMD
      • i-Lumen(TM) AMD Sham
      • Phoenix, Arizona
      • +2 more
      Sep 1, 2022

      Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Beijing (Intravitreal injection of IBI302(dose 1),

      Suspended
      • Neovascular Age-related Macular Degeneration
      • Diabetic Macular Edema
      • Intravitreal injection of IBI302(dose 1)
      • +3 more
      • Beijing, Beijing, China
        Peking University People's Hospital
      Jul 17, 2023

      Therapy of Age-related Macular Degeneration

      Recruiting
      • Age-Related Macular Degeneration
        • Ried Im Innkreis, Upperaustria, Austria
          BHS Ried
        Aug 16, 2022

        Age-Related Macular Degeneration Trial in Beijing (KH631)

        Not yet recruiting
        • Age-Related Macular Degeneration
        • Beijing, China
          Beijing Tongren Hospital, Capital Medical University
        Jan 3, 2023

        Age-related Macular Degeneration, Geographic Atrophy Trial (VOY-101)

        Recruiting
        • Age-related Macular Degeneration
        • Geographic Atrophy
        • VOY-101
        • Bellaire, Texas
          Retina Consultants of Texas
        Nov 17, 2022

        Wet Age-related Macular Degeneration Trial in Beijing (RC28-E, Aflibercept)

        Recruiting
        • Wet Age-related Macular Degeneration
        • Beijing, Beijing, China
          Beijing Hospital
        Feb 3, 2023

        Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Austin (AIV007)

        Not yet recruiting
        • Neovascular Age-related Macular Degeneration
        • Diabetic Macular Edema
        • Austin, Texas
          Retina Consultants of Austin
        Jan 16, 2023

        Neovascular Age-related Macular Degeneration, Diabetic Macular Edema Trial in Mesa, Phoenix (Faricimab PFS Configuration)

        Completed
        • Neovascular Age-related Macular Degeneration
        • Diabetic Macular Edema
        • Faricimab PFS Configuration
        • Mesa, Arizona
        • +2 more
        Jan 2, 2023

        Russian Registry of Patients With nAMD

        Terminated
        • Neovascular Age-Related Macular Degeneration
        • nAMD
        • (no location specified)
        Jan 16, 2023

        VeriSee AMD in Screening for Age-Related Macular Degeneration

        Completed
        • Macular Degeneration, Age Related
        • Maculopathy, Age Related
          • Taipei, Taiwan
            National Taiwan University Hospital
          Oct 23, 2022

          Age-related Macular Degeneration Trial in Israel, United States (OpRegen)

          Completed
          • Age-Related Macular Degeneration
          • OpRegen
          • (no location specified)
          Nov 1, 2022

          Neovascular Age-related Macular Degeneration (NVAMD), Diabetic Macular Edema (DME) Trial in United States (EYE103)

          Recruiting
          • Neovascular Age-related Macular Degeneration (NVAMD)
          • Diabetic Macular Edema (DME)
          • Phoenix, Arizona
          • +4 more
          Jun 14, 2023

          Age-Related Macular Degeneration, Neovascular Age-related Macular Degeneration Trial in Tehran (Aflibercept (CinnaGen Co, Iran),

          Completed
          • Age-Related Macular Degeneration
          • Neovascular Age-related Macular Degeneration
          • Aflibercept (CinnaGen Co, Iran)
          • Aflibercept (Regeneron, USA)
          • Tehran, Iran, Islamic Republic of
            Farabi Hospital
          Oct 16, 2022